| Qi Zhang, MD | |
|
6678 W Thunderbird Rd Ste 100, Glendale, AZ 85306-3721 | |
| (602) 678-1500 | |
| (602) 978-0409 |
| Full Name | Qi Zhang |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 17 Years |
| Location | 6678 W Thunderbird Rd Ste 100, Glendale, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285773887 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 36181 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Desert West Obstetrics And Gynecology Ltd | 3375529100 | 18 |
News Archive
arGEN-X, a clinical stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for the treatment of cancer and severe autoimmune diseases, today announced it has entered into a partnership with The Leukemia & Lymphoma Society (LLS) in which both parties will contribute to the funding of a Phase 2 clinical study of the Company's lead candidate, ARGX-110, in patients with refractory Waldenström's macroglobulinemia (WM).
The Arizona House early Thursday passed an $8.8 billion state budget that includes a proposal to pursue the health law's Medicaid expansion. News outlets also report on related action in Ohio and Michigan.
Punyamurtula S. Kishore MD, MPH, FASAM, of Preventive Medicine Associates, Inc. (PMAI), the largest outpatient substance dependence provider in Massachusetts, announced today his 37 clinical locations will be offering new addiction treatment options through the use of VIVITROL (naltrexone for extended-release injectable suspension), which was approved on Tuesday, October 12, 2010 by the U.S. Food and Drug Administration (FDA) for the prevention of relapse to opioid dependence.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that the rheumatoid arthritis drug market in India will more than double by 2013, growing from $296 million in 2008 to $672 million in 2013.
Nonsense mutations are single-letter errors in the genetic code that prematurely halt the production of critical proteins. These unfinished proteins are unable to function normally, and nonsense mutations cause 10-15 percent of all inherited genetic diseases, including Duchenne muscular dystrophy, spinal muscular atrophy, cystic fibrosis and polycystic kidney disease.
› Verified 9 days ago
| Entity Name | Desert West Obstetrics & Gynecology Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588654560 PECOS PAC ID: 3375529100 Enrollment ID: O20040624000730 |
News Archive
arGEN-X, a clinical stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for the treatment of cancer and severe autoimmune diseases, today announced it has entered into a partnership with The Leukemia & Lymphoma Society (LLS) in which both parties will contribute to the funding of a Phase 2 clinical study of the Company's lead candidate, ARGX-110, in patients with refractory Waldenström's macroglobulinemia (WM).
The Arizona House early Thursday passed an $8.8 billion state budget that includes a proposal to pursue the health law's Medicaid expansion. News outlets also report on related action in Ohio and Michigan.
Punyamurtula S. Kishore MD, MPH, FASAM, of Preventive Medicine Associates, Inc. (PMAI), the largest outpatient substance dependence provider in Massachusetts, announced today his 37 clinical locations will be offering new addiction treatment options through the use of VIVITROL (naltrexone for extended-release injectable suspension), which was approved on Tuesday, October 12, 2010 by the U.S. Food and Drug Administration (FDA) for the prevention of relapse to opioid dependence.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that the rheumatoid arthritis drug market in India will more than double by 2013, growing from $296 million in 2008 to $672 million in 2013.
Nonsense mutations are single-letter errors in the genetic code that prematurely halt the production of critical proteins. These unfinished proteins are unable to function normally, and nonsense mutations cause 10-15 percent of all inherited genetic diseases, including Duchenne muscular dystrophy, spinal muscular atrophy, cystic fibrosis and polycystic kidney disease.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Qi Zhang, MD 6678 W Thunderbird Rd Ste 100, Glendale, AZ 85306-3721 Ph: (602) 678-1500 | Qi Zhang, MD 6678 W Thunderbird Rd Ste 100, Glendale, AZ 85306-3721 Ph: (602) 678-1500 |
News Archive
arGEN-X, a clinical stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for the treatment of cancer and severe autoimmune diseases, today announced it has entered into a partnership with The Leukemia & Lymphoma Society (LLS) in which both parties will contribute to the funding of a Phase 2 clinical study of the Company's lead candidate, ARGX-110, in patients with refractory Waldenström's macroglobulinemia (WM).
The Arizona House early Thursday passed an $8.8 billion state budget that includes a proposal to pursue the health law's Medicaid expansion. News outlets also report on related action in Ohio and Michigan.
Punyamurtula S. Kishore MD, MPH, FASAM, of Preventive Medicine Associates, Inc. (PMAI), the largest outpatient substance dependence provider in Massachusetts, announced today his 37 clinical locations will be offering new addiction treatment options through the use of VIVITROL (naltrexone for extended-release injectable suspension), which was approved on Tuesday, October 12, 2010 by the U.S. Food and Drug Administration (FDA) for the prevention of relapse to opioid dependence.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that the rheumatoid arthritis drug market in India will more than double by 2013, growing from $296 million in 2008 to $672 million in 2013.
Nonsense mutations are single-letter errors in the genetic code that prematurely halt the production of critical proteins. These unfinished proteins are unable to function normally, and nonsense mutations cause 10-15 percent of all inherited genetic diseases, including Duchenne muscular dystrophy, spinal muscular atrophy, cystic fibrosis and polycystic kidney disease.
› Verified 9 days ago
Dr. Elizabeth V Mahour-moyer, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6678 W Thunderbird Rd, Glendale, AZ 85306 Phone: 602-978-1500 Fax: 602-978-0409 | |
Mrs. Amy Blanshard Boots, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6678 W Thunderbird Rd, Glendale, AZ 85306 Phone: 602-678-1500 Fax: 602-978-0409 | |
Emily Caroline Fanning, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 6678 W Thunderbird Rd, Glendale, AZ 85306 Phone: 026-978-1500 Fax: 602-978-0409 | |
Bradley John Folkestad, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 18699 N 67th Ave, Ste 320, Glendale, AZ 85308 Phone: 623-561-7250 Fax: 623-561-0098 | |
Dr. Kelly Ann Goad, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6678 W Thunderbird Rd, Glendale, AZ 85306 Phone: 602-978-1500 Fax: 602-978-0409 | |
Ole Borch-christensen, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 5601 W Eugie Ave, Ste 100, Glendale, AZ 85304 Phone: 602-978-1500 Fax: 602-978-0409 | |
Hillary H. Charles, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5757 W. Thunderbird Road, Suite W-202, Glendale, AZ 85306 Phone: 602-678-1111 Fax: 602-678-7090 |